Donna Welch
Pain Medicine · Morristown, TNNPI 1881123388
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AstraZeneca at 26.9% of the total. Reporting peaked in 2021 at $214 and has fallen 58.6% since, to $89 in 2025. That places this record below the midpoint for pain medicine clinicians in TN, where the typical reported total is $2,322.
Across 37 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$172
- Vifor Pharma, Inc.$119
- AbbVie$73
- Organon$57
- Boston Scientific$36
- Lilly USA, LLC$36
- plus $147 from 8 others
What the payments were for
- Food & beverage$61596%
- Education$244%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $172 |
| Vifor Pharma, Inc. | 7 | $119 |
| AbbVie | 4 | $73 |
| Organon | 3 | $57 |
| Boston Scientific | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Novo Nordisk | 2 | $33 |
| Inogen, Inc. | 1 | $22 |
| Shield Therapeutics Inc | 1 | $18 |
| Avion Pharmaceuticals | 1 | $16 |
| Cashflow Solutions, LLC | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Exeltis, USA Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $13 |
How this compares
$640 in reported general payments places this provider in the 30th percentile of 112 pain medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 16 | $183 |
| Buspirone Hcl | 12 | $177 |
| Chlorthalidone | 14 | $153 |
| Amlodipine Besylate | 22 | $89 |
| Atorvastatin Calcium | 11 | $67 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Morristown
- Shravani DurbhakulaNashville$353K
- Joseph DichiaraKnoxville$102K
- Stephanie VanterpoolKnoxville$69K
- Herbert MeltzerNashville$43K
- Marc HuntoonNashville$37K
- Gregory BallChattanooga$35K
- Phillip GreenMemphis$34K
- Puneet MishraNashville$32K
- John BlakeChattanooga$28K
- Andrew DudasMemphis$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.